Advisors Preferred’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Advisors Preferred’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-218	Closed	-$8K	–	188
2020 Q1	$8K	Buy	+218	New	+$9.29K	﹤0.01%	109
2019 Q2	–	Sell	-1,099	Closed	-$46K	–	299
2019 Q1	$46K	Buy	+1,099	New	+$44.7K	0.01%	154
2018 Q4	–	Sell	-2,495	Closed	-$121K	–	227
2018 Q3	$121K	Buy	+2,495	New	+$118K	0.05%	97
2015 Q2	–	Sell	-36,746	Closed	-$2.27M	–	296
2015 Q1	$2.27M	Buy	+36,746	New	+$2.18M	1.2%	24
2014 Q4	–	Sell	-6,236	Closed	-$331K	–	354
2014 Q3	$331K	Sell	6,236 -23,364	-79%	-$1.19M	0.21%	59
2014 Q2	$1.54M	Sell	29,600 -4,228	-12%	-$204K	0.78%	43
2014 Q1	$1.58M	Sell	33,828 -13,582	-29%	-$641K	0.72%	51
2013 Q4	$2.08M	Buy	+47,410	New	+$1.97M	1.15%	28

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FMP

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Advisors Preferred's XPH Position: Q2 2020 in Review

Advisors Preferred sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2020, closing a stake of 218 shares — an estimated $8K sold.

Advisors Preferred first reported a position in XPH in Q4 2013 and held it in 8 quarters. The position peaked at $2.27M in Q1 2015. 73 funds tracked by Wall St. Rank hold XPH as of Q2 2020.

Advisors Preferred reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
Advisors Preferred sold 218 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2020, an estimated $8K.
Advisors Preferred first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and held it in 8 quarters.
Advisors Preferred's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.27M in Q1 2015.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2020.

Based on Advisors Preferred's 13F filing for Q2 2020, filed 11 Aug 2020.